Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Nature ; 553(7689): 486-490, 2018 01 24.
Article in English | MEDLINE | ID: mdl-29368704

ABSTRACT

Free-space volumetric displays, or displays that create luminous image points in space, are the technology that most closely resembles the three-dimensional displays of popular fiction. Such displays are capable of producing images in 'thin air' that are visible from almost any direction and are not subject to clipping. Clipping restricts the utility of all three-dimensional displays that modulate light at a two-dimensional surface with an edge boundary; these include holographic displays, nanophotonic arrays, plasmonic displays, lenticular or lenslet displays and all technologies in which the light scattering surface and the image point are physically separate. Here we present a free-space volumetric display based on photophoretic optical trapping that produces full-colour graphics in free space with ten-micrometre image points using persistence of vision. This display works by first isolating a cellulose particle in a photophoretic trap created by spherical and astigmatic aberrations. The trap and particle are then scanned through a display volume while being illuminated with red, green and blue light. The result is a three-dimensional image in free space with a large colour gamut, fine detail and low apparent speckle. This platform, named the Optical Trap Display, is capable of producing image geometries that are currently unobtainable with holographic and light-field technologies, such as long-throw projections, tall sandtables and 'wrap-around' displays.

3.
Am J Obstet Gynecol ; 177(3): 666-72, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9322640

ABSTRACT

OBJECTIVE: Our purpose was to determine whether cultured human decidual cells produce chemokines in response to different strains of group B streptococci and purified bacterial cell wall components. STUDY DESIGN: Human decidual cells were cultured from term placentas by standard techniques. Different strains of group B streptococci were isolated from neonates with early-onset group B streptococci sepsis. Confluent cell monolayers were incubated with these different strains of group B streptococci and various concentrations of purified bacterial cell wall components (including lipoteichoic acid, sialic acid, lipopolysaccharide, and lipid A) for 16 hours at 37 degrees C. Culture supernatants were collected and assayed for macrophage inflammatory protein-1 alpha and interleukin-8. Statistical analysis was by analysis of variance. RESULTS: We found that cultured human decidual cells produced significant amounts of the two chemokines macrophage inflammatory protein-1 alpha and interleukin-8 in a strain-specific fashion to the various different strains of group B streptococci tested, from 215% to 421% over baseline production (p < 0.05 by analysis of variance). Also, we found that incubation of decidual cells with various concentrations of lipoteichoic acid, sialic acid, lipopolysaccharide, and lipid A resulted in significant concentration-dependent increases in decidual cell macrophage inflammatory protein-1 alpha and interleukin-8 production (p < 0.05.) CONCLUSIONS: Decidual cells produced significant amounts of the chemokines macrophage inflammatory protein-1 alpha and interleukin-8 in response to intact group B streptococci in a strain-specific fashion and in response to various concentrations of different bacterial cell wall components. Because chemokines are important mediators signaling migration of different immune effector cells into areas of inflammation, we suggest that decidual cell chemokine production in response to bacteria and bacterial cell wall components may be a key early event in the pathogenesis of infection-associated preterm labor.


Subject(s)
Cytokines/biosynthesis , Decidua/metabolism , Lipid A/pharmacology , Lipopolysaccharides/pharmacology , N-Acetylneuraminic Acid/pharmacology , Streptococcus agalactiae/physiology , Teichoic Acids/pharmacology , Analysis of Variance , Cell Wall/chemistry , Cell Wall/ultrastructure , Cells, Cultured , Chemokine CCL4 , Decidua/cytology , Dose-Response Relationship, Drug , Enzyme-Linked Immunosorbent Assay , Female , Humans , Interleukin-8/metabolism , Lipid A/analysis , Lipopolysaccharides/analysis , Macrophage Inflammatory Proteins/metabolism , N-Acetylneuraminic Acid/analysis , Pregnancy , Streptococcus agalactiae/ultrastructure , Teichoic Acids/analysis
4.
Clin Ther ; 19(3): 507-19, 1997.
Article in English | MEDLINE | ID: mdl-9220215

ABSTRACT

The objective of this double-masked, parallel-group, multicenter, inpatient study was to compare bromfenac with an acetaminophen/oxycodone combination and ibuprofen in patients who had pain due to abdominal gynecologic surgery. In the 8-hour, single-dose phase, 238 patients received single oral doses of bromfenac (50 or 100 mg), acetaminophen 650 mg/oxycodone 10 mg, ibuprofen 400 mg, or placebo. In the multiple-dose phase, 204 patients received bromfenac, acetaminophen/oxycodone, or ibuprofen for up to 5 days. In the single-dose phase, both bromfenac doses produced peak analgesic responses equivalent to acetaminophen/oxycodone, but the responses to bromfenac were longer lasting. Bromfenac produced significantly better overall (8-hour) analgesic summed scores than acetaminophen/oxycodone. Ibuprofen was less efficacious than the other analgesics. The remedication rate was lower in both bromfenac groups than in the other treatment groups. The acetaminophen/oxycodone group reported more somnolence and vomiting. Single doses of bromfenac provided analgesia at least equivalent to that of the acetaminophen/oxycodone combination, with a longer duration of action. Both doses of bromfenac and acetaminophen/oxycodone were superior to ibuprofen in this study.


Subject(s)
Acetaminophen/therapeutic use , Analgesics, Non-Narcotic/therapeutic use , Analgesics, Opioid/therapeutic use , Benzophenones/therapeutic use , Bromobenzenes/therapeutic use , Ibuprofen/therapeutic use , Oxycodone/therapeutic use , Pain, Postoperative/drug therapy , Adolescent , Adult , Aged , Double-Blind Method , Drug Combinations , Female , Genitalia, Female/surgery , Humans , Middle Aged , Pain Measurement
5.
Am J Obstet Gynecol ; 175(4 Pt 1): 1054-6, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8885775

ABSTRACT

OBJECTIVE: We examined clinical value of cervical fetal fibronectin detection by a quantitative enzyme-linked immunosorbent assay as a predictor of preterm delivery in a population (n = 111) of middle-class pregnant women considered to be at low risk for preterm delivery. STUDY DESIGN: In this prospective study, fetal fibronectin samples from cervicovaginal secretions were obtained biweekly from 24 to 34 weeks' gestation. RESULTS: Twenty-two (20%) patients had at least one positive fetal fibronectin test result. Eleven women (10%) were delivered spontaneously at < 37 weeks; seven of these had at least one positive fetal fibronectin test result (positive predictive value = 31.8%, sensitivity = 63.6). An additional three women were delivered prematurely because of other obstetric indications, and all had negative fetal fibronectin test results. The remaining 15 patients with at least one positive fetal fibronectin test result were delivered at term (> or = 37 weeks). Of the seven women with positive fetal fibronectin results who were delivered prematurely, five were delivered within 2 weeks of obtaining a positive result. However, there were no obvious clinical discriminators between true-positive and false-positive fetal fibronectin results. Eighty-nine women tested negative, and 85 of these women were delivered at term (specificity = 82.0%). The negative predictive value of fetal fibronectin as a predictor of term delivery in this low-risk population is 96.6%, with odds ratio = 8.8 (95% confidence interval 1.9 to 40.3), relative risk = 6.9 (95% confidence interval 1.8 to 26.6), and Fisher Exact Test p = 0.007. CONCLUSIONS: Although negative biweekly fetal fibronectin determinations for prediction of preterm delivery in this low-risk obstetric population correlate well with the absence of preterm delivery, they are of limited clinical value for the prediction of preterm birth.


Subject(s)
Fetal Blood , Fibronectins/blood , Obstetric Labor, Premature , Adult , Enzyme-Linked Immunosorbent Assay , Evaluation Studies as Topic , Female , Humans , Predictive Value of Tests , Pregnancy , Prospective Studies , Risk Factors
6.
Science ; 241(4865): 596-7, 1988 Jul 29.
Article in English | MEDLINE | ID: mdl-17774579
7.
Gen Comp Endocrinol ; 53(2): 272-80, 1984 Feb.
Article in English | MEDLINE | ID: mdl-6607861

ABSTRACT

Labeling and mitotic index rhythms were studied in premetamorphic tadpoles under an LD 12:12 with the light phase beginning at 0800 hr. In a 72-hr experiment, control labeling and mitotic index curves showed a peak in the light and a peak in the dark with labeling index rhythms of 12.4, 17.7, and 23.6 hr and a 21.4-hr mitotic index rhythm. Thyroxine (T4) treatment resulted in a marked elevation of labeling index by 24 hr and of mitotic index by 48 hr, obscured the control bimodal pattern of peaks, and altered the rhythms. During the first 3 days of T4 treatment, a labeling index rhythm of 22 hr and a mitotic index rhythm of 37.5 hr occurred. However, additional work demonstrated that the dominant control rhythms of labeling and mitotic indices returned in the T4-treated during Days 4 and 5. The same pattern of change in labeling index occurred during Day 3 of T4 treatment when hormone administration began at different times in the diurnal phase of the light-dark cycle. The findings suggest that cell proliferation rhythms can be temporarily disturbed by an exogenous T4 stimulus without apparent reference to the phase of the circadian rhythm.


Subject(s)
Cell Division/drug effects , Circadian Rhythm , Rana pipiens/anatomy & histology , Thyroxine/pharmacology , Animals , Female , Larva/drug effects , Skin/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...